The Food and Drug Administration has granted approval to AliveCor for its smartphone-based atrial fibrillation detection algorithm.

The company says the algorithm instantly detects if patients are experiencing AFib through real-time electrocardiogram recordings taken on a mobile phone-based AliveCor Heart Monitor, so physicians can intervene before potentially life-threatening conditions, like strokes, occur. Through AliveCor’s ECG analysis service, patients can confirm their results with a U.S. board-certified cardiologist or a personal physician.

The monitor is compatible with all iPhone models and most Android mobile devices. Users will continue to have the ability to access their data confidentially anytime, anywhere, according to the company.

AliveCor President Euan Thomson said the company plans to make the new algorithm available in September.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access